Abstract
The human tyrosinase ectodomain has been expressed in Escherichia coli as a soluble form and purified by immobilized metal affinity column chromatography. The ectodomain exhibited tyrosinase activities toward the hydroxylation and oxidation reactions. Biochemical properties of the ectodomain appeared to be distinct from those of the human tyrosinase, although common features were retained.
Keywords: Biochemical properties, Ectodomain, Expression in Escherichia coli, Human tyrosinase
Protein & Peptide Letters
Title: Characterization of Human Tyrosinase Ectodomain Expressed in Escherichia coli
Volume: 17 Issue: 8
Author(s): Ji-Na Kong, Hee-Jin Lee, Dong-Hyun Jo and Kwang-Hoon Kong
Affiliation:
Keywords: Biochemical properties, Ectodomain, Expression in Escherichia coli, Human tyrosinase
Abstract: The human tyrosinase ectodomain has been expressed in Escherichia coli as a soluble form and purified by immobilized metal affinity column chromatography. The ectodomain exhibited tyrosinase activities toward the hydroxylation and oxidation reactions. Biochemical properties of the ectodomain appeared to be distinct from those of the human tyrosinase, although common features were retained.
Export Options
About this article
Cite this article as:
Kong Ji-Na, Lee Hee-Jin, Jo Dong-Hyun and Kong Kwang-Hoon, Characterization of Human Tyrosinase Ectodomain Expressed in Escherichia coli, Protein & Peptide Letters 2010; 17 (8) . https://dx.doi.org/10.2174/092986610791498957
DOI https://dx.doi.org/10.2174/092986610791498957 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Strategies for Integral Metabolism Profile of Multiple Compounds in Herbal Medicines: Pharmacokinetics, Metabolites Characterization and Metabolic Interactions
Current Drug Metabolism Preparation and Primary Bioevaluation of 99mTc-labeled-1-thio-β-D-Glucose as Melanoma Targeting Agent
Current Radiopharmaceuticals Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry Inhibitors of the Chemokine Receptor CXCR4: Chemotherapy of AIDS, Metastatic Cancer, Leukemia and Rheumatoid Arthritis
Letters in Drug Design & Discovery Identification of Vβ7.1_H3F7 as a Therapeutic Gene Encoding TCR Specific to Hepatocellular Carcinoma
Current Gene Therapy Cationic Liposomes as Non-viral Vector for RNA Delivery in Cancer Immunotherapy
Recent Patents on Drug Delivery & Formulation Vitamin D and Vitamin D Analogs in Cancer Treatment
Current Drug Targets Plant Ribonucleases and Nucleases as Antiproliferative Agens Targeting Human Tumors Growing in Mice
Recent Patents on DNA & Gene Sequences The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine Ranolazine : Effects on Ischemic Heart
Recent Patents on Cardiovascular Drug Discovery Drug Discovery and the Impact of the Safe Harbor Provision of the Hatch-Waxman Act
Current Topics in Medicinal Chemistry Modified Polysaccharides as Versatile Materials in Controlled Delivery of Antidegenerative Agents
Current Pharmaceutical Design Priority Strategies for Sustainable Fight Against HIV/AIDS in Low-Income Countries
Current HIV Research Regulation of Ingestive Behavior, the Upper Gastrointestinal Motility and Gastric Acid Secretion by Ghrelin in Mammals
Current Nutrition & Food Science Targeting Cancer Cells with Photoactive Silica Nanoparticles
Current Pharmaceutical Design Management of Postoperative Nausea and Vomiting in Women Undergoing Major Gynecological Surgery: A Review and Update
Current Drug Therapy Overcoming Drug Resistance and Treating Advanced Prostate Cancer
Current Drug Targets Molecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective
Current Drug Metabolism Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry